We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Bristol Myers Squibb Co | NYSE:BMY | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.13 | 0.30% | 44.07 | 44.47 | 43.728 | 43.87 | 6,695,404 | 18:56:27 |
From May 2019 to May 2024
Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Leerink Annual Global Healthcare Conference on Thursday, February 15, 2018, in New York. Giovanni Caforio, chief executive officer and chairman, will answer questions about the company at 9:00 a.m. EST.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180208005023/en/
Bristol-Myers Squibb CompanyMedia:Ken Dominski, 609-252-5251ken.dominski@bms.comorInvestors:Tim Power, 609-252-7509timothy.power@bms.comorBill Szablewski, 609-252-5894william.szablewski@bms.com
1 Year Bristol Myers Squibb Chart |
1 Month Bristol Myers Squibb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
